Medical Therapy for Obesity

Barham K. Abu Dayyeh, Lee M. Kaplan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The large number of people with mild to moderate obesity contribute more to its overall public health burdens than the smaller number of people with severe obesity. High-risk, high-efficacy strategies and population strategies focusing on lifestyle and behavioral modifications have failed to address the population burden of disease. An individualized approach is likely to provide the most effective management of this disease for the largest number of patients. This review discusses advances in pharmacologic therapies for obesity with a focus on currently approved drugs and those in later stages of development.

Original languageEnglish (US)
Pages (from-to)203-212
Number of pages10
JournalGastrointestinal Endoscopy Clinics of North America
Volume21
Issue number2
DOIs
StatePublished - Apr 2011
Externally publishedYes

Fingerprint

Obesity
Morbid Obesity
Disease Management
Population
Life Style
Public Health
Therapeutics
Pharmaceutical Preparations

Keywords

  • Diet
  • Lifestyle modification
  • Medications
  • Obesity
  • Pharmacotherapy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Medical Therapy for Obesity. / Abu Dayyeh, Barham K.; Kaplan, Lee M.

In: Gastrointestinal Endoscopy Clinics of North America, Vol. 21, No. 2, 04.2011, p. 203-212.

Research output: Contribution to journalArticle

Abu Dayyeh, Barham K. ; Kaplan, Lee M. / Medical Therapy for Obesity. In: Gastrointestinal Endoscopy Clinics of North America. 2011 ; Vol. 21, No. 2. pp. 203-212.
@article{fa15236780d24477ba28dcae3f9e5a51,
title = "Medical Therapy for Obesity",
abstract = "The large number of people with mild to moderate obesity contribute more to its overall public health burdens than the smaller number of people with severe obesity. High-risk, high-efficacy strategies and population strategies focusing on lifestyle and behavioral modifications have failed to address the population burden of disease. An individualized approach is likely to provide the most effective management of this disease for the largest number of patients. This review discusses advances in pharmacologic therapies for obesity with a focus on currently approved drugs and those in later stages of development.",
keywords = "Diet, Lifestyle modification, Medications, Obesity, Pharmacotherapy",
author = "{Abu Dayyeh}, {Barham K.} and Kaplan, {Lee M.}",
year = "2011",
month = "4",
doi = "10.1016/j.giec.2011.02.006",
language = "English (US)",
volume = "21",
pages = "203--212",
journal = "Gastrointestinal Endoscopy Clinics of North America",
issn = "1052-5157",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Medical Therapy for Obesity

AU - Abu Dayyeh, Barham K.

AU - Kaplan, Lee M.

PY - 2011/4

Y1 - 2011/4

N2 - The large number of people with mild to moderate obesity contribute more to its overall public health burdens than the smaller number of people with severe obesity. High-risk, high-efficacy strategies and population strategies focusing on lifestyle and behavioral modifications have failed to address the population burden of disease. An individualized approach is likely to provide the most effective management of this disease for the largest number of patients. This review discusses advances in pharmacologic therapies for obesity with a focus on currently approved drugs and those in later stages of development.

AB - The large number of people with mild to moderate obesity contribute more to its overall public health burdens than the smaller number of people with severe obesity. High-risk, high-efficacy strategies and population strategies focusing on lifestyle and behavioral modifications have failed to address the population burden of disease. An individualized approach is likely to provide the most effective management of this disease for the largest number of patients. This review discusses advances in pharmacologic therapies for obesity with a focus on currently approved drugs and those in later stages of development.

KW - Diet

KW - Lifestyle modification

KW - Medications

KW - Obesity

KW - Pharmacotherapy

UR - http://www.scopus.com/inward/record.url?scp=79955741633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955741633&partnerID=8YFLogxK

U2 - 10.1016/j.giec.2011.02.006

DO - 10.1016/j.giec.2011.02.006

M3 - Article

C2 - 21569973

AN - SCOPUS:79955741633

VL - 21

SP - 203

EP - 212

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 2

ER -